Doped Halloysite Nanotubes for Use in the 3D Printing of Medical Devices

• Main Authors: Jeffery A. Weisman, Udayabhanu Jammalamadaka, Karthik Tappa, David K. Mills
• Format: Article
• Language: English
• Published: MDPI AG 2017-12-01
• Series: Bioengineering
• Subjects: 3D printing; drug delivery; halloysite nanotubes; nanotechnology
• Online Access: https://www.mdpi.com/2306-5354/4/4/96

Previous studies have established halloysite nanotubes (HNTs) as viable nanocontainers capable of sustained release of a variety of antibiotics, corrosion agents, chemotherapeutics and growth factors either from their lumen or in outer surface coatings. Accordingly, halloysite nanotubes (HNTs) hold great promise as drug delivery carriers in the fields of pharmaceutical science and regenerative medicine. This study explored the potential of 3D printing drug doped HNT constructs. We used a model drug, gentamicin (GS) and polylactic acid (PLA) to fabricate GS releasing disks, beads, and pellets. Gentamicin was released from 3D printed constructs in a sustained manner and had a superior anti-bacterial growth inhibition effect that was dependent on GS doping concentration. While this study focused on a model drug, gentamicin, combination therapy is possible through the fabrication of medical devices containing HNTs doped with a suite of antibiotics or antifungals. Furthermore, tailored dosage levels, suites of antimicrobials, delivered locally would reduce the toxicity of individual agents, prevent the emergence of resistant strains, and enable the treatment of mixed infections.